Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Silicon Valley’s Portfolia Launches Nation’s First FemTech Fund

First of its kind fund dedicated solely to FemTech is launched by female-led firm

Portfolia Funds, innovative venture investing platform, just announced the launch of its sixth fund. The Portfolia FemTech Fund will invest exclusively in emerging technologies, products and services focused on improving women’s health and wellness.

Frost and Sullivan recently published a report stating that FemTech will be a $50 billion market by 2025. Spurred on by rapid innovation in the health space, a positive regulatory environment and the fact that women now control 80% of healthcare decisions in the U.S. household, FemTech is predicted to be the next big disruptor in the global healthcare market. While the benefits of FemTech are widely recognized, the market is still at an early stage.

“It is our investment philosophy to focus on opportunities in high-growth potential segments that are unfulfilled by the traditional venture capital marketplace while being guided by some of the strongest experts in the industry,” says Portfolia Co-Founder and CEO Trish Costello. “For the first time ever, women have the majority of the wealth in the U.S., and are beginning to embrace their power as market makers. They are vocal in their intent to make investments that both have an impact and see returns – the FemTech Fund is a natural fit for this growing market.”

Portfolia Funds has brought on multiple expert investors to lead and advise the Femtech Fund, including: Dr. Mary Lake Polan, MD, PHD, MPH – Stanford University Retired Chair of Department of Obstetrics and Gynecology; Faz K. Bashi, MD – Retired Chair of Medical Device and Digital Health Screening Committees at Life Science Angels (LSA); Nola Masterson – Biotech Business Executive, Venture Capital Investor and Chair Emeritus at California Life Sciences Institute; and Darshana Zaveri – General Partner and member of Catalyst Health Venture’s investment committee. Portfolia’s FemTech Fund is the nation’s first fund dedicated solely to this nascent industry.

“Only 1.4% of healthcare investing by professional venture capitalists is put to work to find solutions in the women’s health space – or FemTech. 80% of healthcare VC’s have never invested in healthcare for women,” Masterson comments. “This underserved market enables Portfolia to access the best deals with very reasonable valuations. I’m excited about the quantity and caliber of companies that are coming across my desk.”

Portfolia is no stranger to investing in cutting-edge companies in the FemTech space. The venture investment group firm has most recently funded JoyLux, run by the former Clarisonic/Sonicare team, which has an innovative product suite to address bladder control and post-partum vaginal rejuvenation. Madorra, the first non-hormonal treatment to address vaginal dryness, and Sandstone Diagnostics, a fertility tracking company join JoyLux as promising Portfolia investments in the FemTech space.

Faz K. Bashi adds, “I’m thrilled to able to head up a fund focused on improving the health, wellness, and lives of women by bringing emerging women’s health solutions to market at a time when there is such market opportunity. Portfolia takes the diversification and management of more traditional venture and layers in more opportunities for education and engagement. I’m thrilled to be part of their mission to build an investment community of 100,000 women venture investors by 2022.”